Judy L. Cannon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Judy L. Cannon has a total of 241 co-authors. Here are the top co-authors by number of shared publications:
- Anne I. Sperling
Department of Medicine, University of Virginia, Charlottesville, VA, USA
7 shared publications Bryan S. Clay
Committee on Immunology & Section of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America
7 shared publications- Janis K. Burkhardt
Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania 3 Department of Pathology and Laboratory Medicine Philadelphia, PA 19104
5 shared publications Melanie E. Moses
Moses Biological Computation Laboratory, Department of Computer Science, University of New Mexico, Albuquerque, NM, United States
5 shared publicationsTamson V. Moore
Committee on Immunology & Section of Pulmonary and Critical Care Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America
5 shared publicationsHozefa S. Bandukwala
Committee on Immunology, University of Chicago, Chicago, Illinois, United States of America
4 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by Springer Nature in Research Square
Spatial Immune Model of Alveolar Lung Infection (SIMALI) Identifies Structural Determinants of Lung Inflammation
Inflammation and lung damage in response to respiratory viral infection is a major cause of morbidity and mortality. How specialized lung alveolar structures contribute to variation in inflammatory lung damage observed in patients is a gap in current knowledge. Filling this gap is important for understanding how respiratory infections can lead to persistent and chronic sequelae after acute viral infection, including post-acute sequelae of COVID-19, or "long COVID". Few computational models have incorporated the spatial complexity of alveolar sacs, key sites where infection and inflammation damage lung function. We propose a novel computational model, SIMALI, which represents a sample of the lung's alveolar space as a structured 3D lattice of alveoli composed of air and epithelial cells surrounded by structural lung tissue through which virus and inflammation diffuse. SIMALI extends a previous agent-based model by adding key structural components of the lung, including physiological percentages of infectable cells and differential diffusion of virus through air and lung tissue. SIMALI's simulation predictions are validated against the spatial-temporal growth of lung lesions from Computed Tomography (CT) scans of patients with SARS-CoV-2 infection. By combining parameters validated in a prior study with alveolar structure, the model accurately predicts the typical growth of lung inflammation observed in patient CT scans. SIMALI demonstrates how the spatial architecture of alveolar sacs and the distribution of infectable cell types in the lung constrain the spread of virus and inflammation. Furthermore, SIMALI simulations show how the initial deposition of foci of viral infection distributed across alveolar sacs is an important mechanistic cause of variation in lung damage due to inflammation. The spatial SIMALI model demonstrates a key role for the structure of the alveolar space in driving inflammatory responses. Lung alveolar structure, combined with variation in immune response and the amount and location of initial viral deposition in the lung, all contribute to the highly variable damage to lung recapitulating variation observed across patients with SARS-CoV-2 infection.
- 24 June 2026
- Published by Springer Nature in Research Square
Open AccessSpatial Immune Model of Alveolar Lung Infection (SIMALI) Identifies Structural Determinants of Lung Inflammation
Inflammation and lung damage in response to respiratory viral infection is a major cause of morbidity and mortality. How specialized lung alveolar structures contribute to variation in inflammatory lung damage observed in patients is a gap in current knowledge. Filling this gap is important for understanding how respiratory infections can lead to persistent and chronic sequelae after acute viral infection, including post-acute sequelae of COVID-19, or "long COVID". Few computational models have incorporated the spatial complexity of alveolar sacs, key sites where infection and inflammation damage lung function. We propose a novel computational model, SIMALI, which represents a sample of the lung's alveolar space as a structured 3D lattice of alveoli composed of air and epithelial cells surrounded by structural lung tissue through which virus and inflammation diffuse. SIMALI extends a previous agent-based model by adding key structural components of the lung, including physiological percentages of infectable cells and differential diffusion of virus through air and lung tissue. SIMALI's simulation predictions are validated against the spatial-temporal growth of lung lesions from Computed Tomography (CT) scans of patients with SARS-CoV-2 infection. By combining parameters validated in a prior study with alveolar structure, the model accurately predicts the typical growth of lung inflammation observed in patient CT scans. SIMALI demonstrates how the spatial architecture of alveolar sacs and the distribution of infectable cell types in the lung constrain the spread of virus and inflammation. Furthermore, SIMALI simulations show how the initial deposition of foci of viral infection distributed across alveolar sacs is an important mechanistic cause of variation in lung damage due to inflammation. The spatial SIMALI model demonstrates a key role for the structure of the alveolar space in driving inflammatory responses. Lung alveolar structure, combined with variation in immune response and the amount and location of initial viral deposition in the lung, all contribute to the highly variable damage to lung recapitulating variation observed across patients with SARS-CoV-2 infection.
- Open Access
- 6 January 2026
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 10 (1)
Interleukin-7R and chemokine receptor type 7 differentially regulate metabolism in CD4+ and CD8+ T cells
Naïve T cells are highly metabolically active, maintaining homeostatic function as well as continuously moving and surveying lymph nodes for dendritic cells (DCs) presenting cognate antigen. T-cell metabolism is thought to change throughout development: Naïve T cells have been found to predominantly utilize catabolism for naïve T-cell homeostasis while T-cell activation leads effector T cells to become glycolytic. There is still relatively less known about how individual and combinations of molecular signals drive specific metabolic programs in naïve T cells. Naïve T cells primarily depend on IL-7 signaling to IL-7R for homeostasis and are driven by the chemokine receptor CCR7 responding to CCL21 for rapid motility in lymph nodes, leading to T-cell surveillance. We identify specific roles for IL-7R and CCR7 in driving differential metabolic programs in naïve CD8+ and CD4+ T cells. We find that while IL-7 treatment increases glycolysis in both naïve CD4+ and CD8+ T cells, CCL21 treatment does not affect glycolysis. Instead, CCR7 signaling decreases respiratory capacity and mitochondrial intensity and area. While IL-7 treatment does not impact overall oxidative phosphorylation, IL-7 also alters mitochondrial dynamics. Interestingly, a combination of IL-7R and CCR7 signaling using IL-7 with CCL21 differentially affects CD4+ versus CD8+ T-cell metabolism. Our results demonstrate that multiple molecular signals can differentially regulate naïve CD4+ and CD8+ T-cell metabolism, leading to changes in both glycolysis and oxidative phosphorylation in naïve T cells.
- 6 January 2026
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 10 (1)
Open AccessInterleukin-7R and chemokine receptor type 7 differentially regulate metabolism in CD4+ and CD8+ T cells
Naïve T cells are highly metabolically active, maintaining homeostatic function as well as continuously moving and surveying lymph nodes for dendritic cells (DCs) presenting cognate antigen. T-cell metabolism is thought to change throughout development: Naïve T cells have been found to predominantly utilize catabolism for naïve T-cell homeostasis while T-cell activation leads effector T cells to become glycolytic. There is still relatively less known about how individual and combinations of molecular signals drive specific metabolic programs in naïve T cells. Naïve T cells primarily depend on IL-7 signaling to IL-7R for homeostasis and are driven by the chemokine receptor CCR7 responding to CCL21 for rapid motility in lymph nodes, leading to T-cell surveillance. We identify specific roles for IL-7R and CCR7 in driving differential metabolic programs in naïve CD8+ and CD4+ T cells. We find that while IL-7 treatment increases glycolysis in both naïve CD4+ and CD8+ T cells, CCL21 treatment does not affect glycolysis. Instead, CCR7 signaling decreases respiratory capacity and mitochondrial intensity and area. While IL-7 treatment does not impact overall oxidative phosphorylation, IL-7 also alters mitochondrial dynamics. Interestingly, a combination of IL-7R and CCR7 signaling using IL-7 with CCL21 differentially affects CD4+ versus CD8+ T-cell metabolism. Our results demonstrate that multiple molecular signals can differentially regulate naïve CD4+ and CD8+ T-cell metabolism, leading to changes in both glycolysis and oxidative phosphorylation in naïve T cells.
- Open Access
IL-7 promotes naïve T cell motility to enable T cell scanning of dendritic cells in the LN
- Open Access
OCT4 Negatively Regulates the Transcriptional Programming of the Early Region 3 Immune Evasion Genes of Human Adenovirus
Genomes of viruses are constrained by the virions’ nanoscale, and viral nucleotide sequences without function are a luxury. Yet the double-stranded DNA genome of human adenovirus (HAdV) contains large regions without known purpose. Using TRANSFAC and ChIP-Seq analysis, we identified binding of OCT4 (octomer-binding transcription factor 4) to a noncoding region of HAdV-D37 DNA. Manipulation of OCT4 expression impacted viral E3 gene transcription and gp19k protein expression, altering subsequent MHC Class I expression. These effects were specific to OCT4 binding to the adenovirus 5 ′ inverted terminal repeat (ITR) within nucleotides 101-159. Using targeted mutations to OCT4, we found one of two OCT4 binding motifs in the ITR to be crucial for repression of E3 gene expression. In OCT4-siRNA treated cells, E3 RID-α gene expression was also upregulated to inhibit pro-apoptotic signals, suggesting that OCT4 binding also indirectly represses viral replication. Consistent with a role for transcription factors in epigenetic modification during infections, OCT4 knockdown also reduced histone H3 acetylation and DNA methylation. In stem cells, OCT4 sustains pluripotency, whereas in somatic cells, OCT4 plays a dispensable role in self-renewal and maintenance. Herein, we show that OCT4 binding also confers a previously unidentified function to non-coding adenovirus DNA. Graphical
Open AccessOCT4 Negatively Regulates the Transcriptional Programming of the Early Region 3 Immune Evasion Genes of Human Adenovirus
Genomes of viruses are constrained by the virions’ nanoscale, and viral nucleotide sequences without function are a luxury. Yet the double-stranded DNA genome of human adenovirus (HAdV) contains large regions without known purpose. Using TRANSFAC and ChIP-Seq analysis, we identified binding of OCT4 (octomer-binding transcription factor 4) to a noncoding region of HAdV-D37 DNA. Manipulation of OCT4 expression impacted viral E3 gene transcription and gp19k protein expression, altering subsequent MHC Class I expression. These effects were specific to OCT4 binding to the adenovirus 5 ′ inverted terminal repeat (ITR) within nucleotides 101-159. Using targeted mutations to OCT4, we found one of two OCT4 binding motifs in the ITR to be crucial for repression of E3 gene expression. In OCT4-siRNA treated cells, E3 RID-α gene expression was also upregulated to inhibit pro-apoptotic signals, suggesting that OCT4 binding also indirectly represses viral replication. Consistent with a role for transcription factors in epigenetic modification during infections, OCT4 knockdown also reduced histone H3 acetylation and DNA methylation. In stem cells, OCT4 sustains pluripotency, whereas in somatic cells, OCT4 plays a dispensable role in self-renewal and maintenance. Herein, we show that OCT4 binding also confers a previously unidentified function to non-coding adenovirus DNA. Graphical
- Open Access
- 3 June 2024
- Published by Association for Computing Machinery (ACM)
- p. 322-333
SIMCoV-GPU: Accelerating an Agent-Based Model for Exascale
Modern supercomputers rely on graphics processing units (GPUs) to achieve unprecedented computational capabilities. Multi-node computation with GPUs promises to accelerate and scale simulations dramatically across many domains, and many scientific simulations have been adapted to this new paradigm of supercomputing. However, agent-based models (ABMs) are a class of simulations that to date have seen little development for multinode, multi-GPU supercomputers because their computation flow poses unique algorithmic and communication challenges for effective performance on GPU enabled supercomputers. In particular, many ABMs have irregular and dynamic communication patterns, resource competition that causes race conditions, and unpredictable effects on load balancing. We studied the Spatial Immune Model of Coronavirus, or SIMCoV, as a target ABM application for acceleration. SIMCoV is a large-scale ABM which simulates the spread of viral infection through the epithelial tissue of the lungs and models the immune response with diffusing inflammatory signals and mobile T cell agents. Our multinode, multi-GPU implementation of SIMCoV achieves significant speedups over a competitive baseline version, up to 11.9x with a ratio of 32 CPU cores to a single GPU. The paper describes SIMCoV's GPU-specific optimizations, reports empirical results, and demonstrates effective solutions to the challenges of accelerating ABMs on modern supercomputers.
- 3 June 2024
- Published by Association for Computing Machinery (ACM)
- p. 322-333
Open AccessSIMCoV-GPU: Accelerating an Agent-Based Model for Exascale
Modern supercomputers rely on graphics processing units (GPUs) to achieve unprecedented computational capabilities. Multi-node computation with GPUs promises to accelerate and scale simulations dramatically across many domains, and many scientific simulations have been adapted to this new paradigm of supercomputing. However, agent-based models (ABMs) are a class of simulations that to date have seen little development for multinode, multi-GPU supercomputers because their computation flow poses unique algorithmic and communication challenges for effective performance on GPU enabled supercomputers. In particular, many ABMs have irregular and dynamic communication patterns, resource competition that causes race conditions, and unpredictable effects on load balancing. We studied the Spatial Immune Model of Coronavirus, or SIMCoV, as a target ABM application for acceleration. SIMCoV is a large-scale ABM which simulates the spread of viral infection through the epithelial tissue of the lungs and models the immune response with diffusing inflammatory signals and mobile T cell agents. Our multinode, multi-GPU implementation of SIMCoV achieves significant speedups over a competitive baseline version, up to 11.9x with a ratio of 32 CPU cores to a single GPU. The paper describes SIMCoV's GPU-specific optimizations, reports empirical results, and demonstrates effective solutions to the challenges of accelerating ABMs on modern supercomputers.
- Open Access
- 23 October 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Quantitative analyses of T cell motion in tissue reveals factors driving T cell search in tissues
T cells are required to clear infection, and T cell motion plays a role in how quickly a T cell finds its target, from initial naive T cell activation by a dendritic cell to interaction with target cells in infected tissue. To better understand how different tissue environments affect T cell motility, we compared multiple features of T cell motion including speed, persistence, turning angle, directionality, and confinement of T cells moving in multiple murine tissues using microscopy. We quantitatively analyzed naive T cell motility within the lymph node and compared motility parameters with activated CD8 T cells moving within the villi of small intestine and lung under different activation conditions. Our motility analysis found that while the speeds and the overall displacement of T cells vary within all tissues analyzed, T cells in all tissues tended to persist at the same speed. Interestingly, we found that T cells in the lung show a marked population of T cells turning at close to 180o, while T cells in lymph nodes and villi do not exhibit this “reversing” movement. T cells in the lung also showed significantly decreased meandering ratios and increased confinement compared to T cells in lymph nodes and villi. These differences in motility patterns led to a decrease in the total volume scanned by T cells in lung compared to T cells in lymph node and villi. These results suggest that the tissue environment in which T cells move can impact the type of motility and ultimately, the efficiency of T cell search for target cells within specialized tissues such as the lung.
- 23 October 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Open AccessQuantitative analyses of T cell motion in tissue reveals factors driving T cell search in tissues
T cells are required to clear infection, and T cell motion plays a role in how quickly a T cell finds its target, from initial naive T cell activation by a dendritic cell to interaction with target cells in infected tissue. To better understand how different tissue environments affect T cell motility, we compared multiple features of T cell motion including speed, persistence, turning angle, directionality, and confinement of T cells moving in multiple murine tissues using microscopy. We quantitatively analyzed naive T cell motility within the lymph node and compared motility parameters with activated CD8 T cells moving within the villi of small intestine and lung under different activation conditions. Our motility analysis found that while the speeds and the overall displacement of T cells vary within all tissues analyzed, T cells in all tissues tended to persist at the same speed. Interestingly, we found that T cells in the lung show a marked population of T cells turning at close to 180o, while T cells in lymph nodes and villi do not exhibit this “reversing” movement. T cells in the lung also showed significantly decreased meandering ratios and increased confinement compared to T cells in lymph nodes and villi. These differences in motility patterns led to a decrease in the total volume scanned by T cells in lung compared to T cells in lymph node and villi. These results suggest that the tissue environment in which T cells move can impact the type of motility and ultimately, the efficiency of T cell search for target cells within specialized tissues such as the lung.
- Open Access
- 25 May 2023
- Published by Springer Nature in Respiratory Research
- Vol. 24 (1) , 1-17
Multi-omic assessment shows dysregulation of pulmonary and systemic immunity to e-cigarette exposure
Electronic cigarette (Ecig) use has become more common, gaining increasing acceptance as a safer alternative to tobacco smoking. However, the 2019 outbreak of Ecig and Vaping-Associated Lung Injury (EVALI) alerted the community to the potential for incorporation of deleterious ingredients such as vitamin E acetate into products without adequate safety testing. Understanding Ecig induced molecular changes in the lung and systemically can provide a path to safety assessment and protect consumers from unsafe formulations. While vitamin E acetate has been largely removed from commercial and illicit products, many Ecig products contain additives that remain largely uncharacterized. In this study, we determined the lung-specific effects as well as systemic immune effects in response to exposure to a common Ecig base, propylene glycol and vegetable glycerin (PGVG), with and without a 1% addition of phytol, a diterpene alcohol that has been found in commercial products. We exposed animals to PGVG with and without phytol and assessed metabolite, lipid, and transcriptional markers in the lung. We found both lung-specific as well as systemic effects in immune parameters, metabolites, and lipids. Phytol drove modest changes in lung function and increased splenic CD4 T cell populations. We also conducted multi-omic data integration to better understand early complex pulmonary responses, highlighting a central enhancement of acetylcholine responses and downregulation of palmitic acid connected with conventional flow cytometric assessments of lung, systemic inflammation, and pulmonary function. Our results demonstrate that Ecig exposure not only leads to changes in pulmonary function but also affects systemic immune and metabolic parameters.
- 25 May 2023
- Published by Springer Nature in Respiratory Research
- Vol. 24 (1) , 1-17
Open AccessMulti-omic assessment shows dysregulation of pulmonary and systemic immunity to e-cigarette exposure
Electronic cigarette (Ecig) use has become more common, gaining increasing acceptance as a safer alternative to tobacco smoking. However, the 2019 outbreak of Ecig and Vaping-Associated Lung Injury (EVALI) alerted the community to the potential for incorporation of deleterious ingredients such as vitamin E acetate into products without adequate safety testing. Understanding Ecig induced molecular changes in the lung and systemically can provide a path to safety assessment and protect consumers from unsafe formulations. While vitamin E acetate has been largely removed from commercial and illicit products, many Ecig products contain additives that remain largely uncharacterized. In this study, we determined the lung-specific effects as well as systemic immune effects in response to exposure to a common Ecig base, propylene glycol and vegetable glycerin (PGVG), with and without a 1% addition of phytol, a diterpene alcohol that has been found in commercial products. We exposed animals to PGVG with and without phytol and assessed metabolite, lipid, and transcriptional markers in the lung. We found both lung-specific as well as systemic effects in immune parameters, metabolites, and lipids. Phytol drove modest changes in lung function and increased splenic CD4 T cell populations. We also conducted multi-omic data integration to better understand early complex pulmonary responses, highlighting a central enhancement of acetylcholine responses and downregulation of palmitic acid connected with conventional flow cytometric assessments of lung, systemic inflammation, and pulmonary function. Our results demonstrate that Ecig exposure not only leads to changes in pulmonary function but also affects systemic immune and metabolic parameters.
- Open Access
Quantitative analyses of T cell motion in tissue reveals factors driving T cell search in tissues
T cells are required to clear infection, moving first in lymph nodes to interact with antigen bearing dendritic cells leading to activation. T cells then move to sites of infection to find and clear infection. T cell motion plays a role in how quickly a T cell finds its target, from initial naïve T cell activation by a dendritic cell to interaction with target cells in infected tissue. To better understand how different tissue environments might affect T cell motility, we compared multiple features of T cell motion including speed, persistence, turning angle, directionality, and confinement of motion from T cells moving in multiple tissues using tracks collected with microscopy from murine tissues. We quantitatively analyzed naïve T cell motility within the lymph node and compared motility parameters with activated CD8 T cells moving within the villi of small intestine and lung under different activation conditions. Our motility analysis found that while the speeds and the overall displacement of T cells vary within all tissues analyzed, T cells in all tissues tended to persist at the same speed, particularly if the previous speed is very slow (less than 2 µm /min) or very fast (greater than 8 µm /min) with the exception of T cells in the villi for speeds greater than 10 µm /min. Interestingly, we found that turning angles of T cells in the lung show a marked population of T cells turning at close to 180 o , while T cells in lymph nodes and villi do not exhibit this “reversing” movement. Additionally, T cells in the lung showed significantly decreased meandering ratios and increased confinement compared to T cells in lymph nodes and villi. The combination of these differences in motility patterns led to a decrease in the total volume scanned by T cells in lung compared to T cells in lymph node and villi. These results suggest that the tissue environment in which T cells move can impact the type of motility and ultimately, the efficiency of T cell search for target cells within specialized tissues such as the lung.
Open AccessQuantitative analyses of T cell motion in tissue reveals factors driving T cell search in tissues
T cells are required to clear infection, moving first in lymph nodes to interact with antigen bearing dendritic cells leading to activation. T cells then move to sites of infection to find and clear infection. T cell motion plays a role in how quickly a T cell finds its target, from initial naïve T cell activation by a dendritic cell to interaction with target cells in infected tissue. To better understand how different tissue environments might affect T cell motility, we compared multiple features of T cell motion including speed, persistence, turning angle, directionality, and confinement of motion from T cells moving in multiple tissues using tracks collected with microscopy from murine tissues. We quantitatively analyzed naïve T cell motility within the lymph node and compared motility parameters with activated CD8 T cells moving within the villi of small intestine and lung under different activation conditions. Our motility analysis found that while the speeds and the overall displacement of T cells vary within all tissues analyzed, T cells in all tissues tended to persist at the same speed, particularly if the previous speed is very slow (less than 2 µm /min) or very fast (greater than 8 µm /min) with the exception of T cells in the villi for speeds greater than 10 µm /min. Interestingly, we found that turning angles of T cells in the lung show a marked population of T cells turning at close to 180 o , while T cells in lymph nodes and villi do not exhibit this “reversing” movement. Additionally, T cells in the lung showed significantly decreased meandering ratios and increased confinement compared to T cells in lymph nodes and villi. The combination of these differences in motility patterns led to a decrease in the total volume scanned by T cells in lung compared to T cells in lymph node and villi. These results suggest that the tissue environment in which T cells move can impact the type of motility and ultimately, the efficiency of T cell search for target cells within specialized tissues such as the lung.
- Open Access
CXCR4 controls movement and degranulation of CD8 + T cells in the influenza-infected lung via differential effects on interaction and tissue scanning
Effector CD8 + T cell interactions are critical in controlling viral infection by directly killing infected cells but overabundant or sustained activation also exacerbates tissue damage. Chemokines promote the trafficking of effector CD8 + T cells into infected tissues, but we know little about how chemokines regulate the function of CD8 + T cells within tissues. Using a murine model of influenza A virus infection, we found that expression of the chemokine receptor CXCR4 by lung-infiltrating cytotoxic T cells correlated with the expression of the degranulation marker CD107a. Inhibition of CXCR4 reduced activation, adhesion, and degranulation of cytotoxic T cells in vitro and in vivo . Moreover, in live influenza-infected lung tissue, T cells stopped moving in lung regions with high levels of influenza antigen, and CXCR4 was essential for CD8 + T cells to execute this arrest signal fully. In contrast, CXCR4 increased the motility of CD8 + T cells in low-influenza areas of the lung. We also found that CXCR4 stimulated the effector function of lung-infiltrating cytotoxic T cells even after clearance of influenza virus, and inhibition of CXCR4 expedited the recovery of influenza-infected mice, despite delayed clearance of the replication-competent virus. Our results suggest that CXCR4 promotes the interaction strength of cytotoxic T cells in lung tissue through combined effects on T cell movement and interaction with virally infected target cells in influenza infected-lungs.
Open AccessCXCR4 controls movement and degranulation of CD8 + T cells in the influenza-infected lung via differential effects on interaction and tissue scanning
Effector CD8 + T cell interactions are critical in controlling viral infection by directly killing infected cells but overabundant or sustained activation also exacerbates tissue damage. Chemokines promote the trafficking of effector CD8 + T cells into infected tissues, but we know little about how chemokines regulate the function of CD8 + T cells within tissues. Using a murine model of influenza A virus infection, we found that expression of the chemokine receptor CXCR4 by lung-infiltrating cytotoxic T cells correlated with the expression of the degranulation marker CD107a. Inhibition of CXCR4 reduced activation, adhesion, and degranulation of cytotoxic T cells in vitro and in vivo . Moreover, in live influenza-infected lung tissue, T cells stopped moving in lung regions with high levels of influenza antigen, and CXCR4 was essential for CD8 + T cells to execute this arrest signal fully. In contrast, CXCR4 increased the motility of CD8 + T cells in low-influenza areas of the lung. We also found that CXCR4 stimulated the effector function of lung-infiltrating cytotoxic T cells even after clearance of influenza virus, and inhibition of CXCR4 expedited the recovery of influenza-infected mice, despite delayed clearance of the replication-competent virus. Our results suggest that CXCR4 promotes the interaction strength of cytotoxic T cells in lung tissue through combined effects on T cell movement and interaction with virally infected target cells in influenza infected-lungs.
- Open Access
- 1 March 2022
- Published by Springer Nature in Research Square
IL-7R and CCR7 Regulate Distinct Metabolic Pathways in Naïve T Cells to Promote T Cell Motility
Naïve T cells movement through tissues, including through lymph nodes, requires ongoing energy supply for rapid motility promoting T cell scanning of dendritic cells and T cell activation. Rapid movement is facilitated by signaling through chemokine receptor CCR7, but how signaling to motility relates to T cell metabolism is not well understood. Conversely, whether signals including IL-7R which are known to regulate naïve T cell metabolism might impact motility is not known. We analyze how CCR7 and IL-7R regulate T cell motility and metabolism. Using Seahorse analysis, we find that CCL21 signaling to CCR7 decreases oxidative phosphorylation, but has no effect on glycolysis. In contrast, IL-7 promotes glycolysis but shows no effect on respiration. We demonstrate a previously unidentified role for IL-7/IL-7R in promotion of T cell motility in lymph nodes by imaging T cell movement in lymph nodes after inhibition of IL-7R and IL-7. Downstream of IL-7R, JAK3 and STAT5, but not mTOR, mediates rapid motility. Our results shed new light on how metabolism intersects with motility to promote more efficient T cell movement within lymph nodes to promote potential for DC scanning and interaction, potentially through differential means of ATP production.
- 1 March 2022
- Published by Springer Nature in Research Square
Open AccessIL-7R and CCR7 Regulate Distinct Metabolic Pathways in Naïve T Cells to Promote T Cell Motility
Naïve T cells movement through tissues, including through lymph nodes, requires ongoing energy supply for rapid motility promoting T cell scanning of dendritic cells and T cell activation. Rapid movement is facilitated by signaling through chemokine receptor CCR7, but how signaling to motility relates to T cell metabolism is not well understood. Conversely, whether signals including IL-7R which are known to regulate naïve T cell metabolism might impact motility is not known. We analyze how CCR7 and IL-7R regulate T cell motility and metabolism. Using Seahorse analysis, we find that CCL21 signaling to CCR7 decreases oxidative phosphorylation, but has no effect on glycolysis. In contrast, IL-7 promotes glycolysis but shows no effect on respiration. We demonstrate a previously unidentified role for IL-7/IL-7R in promotion of T cell motility in lymph nodes by imaging T cell movement in lymph nodes after inhibition of IL-7R and IL-7. Downstream of IL-7R, JAK3 and STAT5, but not mTOR, mediates rapid motility. Our results shed new light on how metabolism intersects with motility to promote more efficient T cell movement within lymph nodes to promote potential for DC scanning and interaction, potentially through differential means of ATP production.